SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001467154-23-000051
Filing Date
2023-05-31
Accepted
2023-05-31 16:13:46
Documents
14
Period of Report
2023-05-31
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20230531.htm   iXBRL 8-K 46309
2 EX-99.1 a5312023exhibit991.htm EX-99.1 13476
6 logo.jpg GRAPHIC 17861
  Complete submission text file 0001467154-23-000051.txt   227857

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20230531.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20230531_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20230531_pre.xml EX-101.PRE 12502
8 EXTRACTED XBRL INSTANCE DOCUMENT novn-20230531_htm.xml XML 10839
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

IRS No.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 23981138
SIC: 2834 Pharmaceutical Preparations